Cormorant Global Healthcare Master Fund
3
15M
2
0.33
1
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cormorant Global Healthcare Master Fund, startups are often financed by venBio Partners, Perceptive Advisors, Longwood Capital Partners. The meaningful sponsors for the fund in investment in the same round are venBio Partners, Perceptive Advisors, Longwood Capital Partners. In the next rounds fund is usually obtained by venBio Partners, Sabby Management, Perceptive Advisors.
The fund has exact preference in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Tioga Medical, Outlook Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical Device, Therapeutics.
The higher amount of exits for fund were in 2016. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Cormorant Global Healthcare Master Fund works on 4 percentage points more the average amount of lead investments.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (2)
- Pharmaceutical (2)
- Therapeutics (2)
- Biopharma (2)
- Medical Device (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Tioga Medical | 01 Apr 2019 | Health Care, Medical Device | Early Stage Venture | 14M | United States, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.